Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Amaroli A et al. | 2006 | intact cell/cell culture, <i>Dictyostelium discoideum</i> (amoeba) | magnetic field, 50/60 Hz | 200 µT |
Revoltella RP et al. | 1993 | intact cell/cell culture, Friend erythroleukemia cell line (line 3BM-78, clone H19 from line 5-86, line 707M, clone F4-1 from line F4-N) | magnetic field, 50/60 Hz | 200 µT |
Wang J et al. | 2013 | intact cell/cell culture, human fetal scleral fibroblasts and retinal pigment epithelial cells | magnetic field, 50/60 Hz, co-exposure | 0.2 mT |
Chen L et al. | 2021 | intact cell/cell culture, human amniotic (FL) cells | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 0.2–0.4 mT |
Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
Koh EK et al. | 2008 | intact cell/cell culture, different human prostate carcinoma cell lines (DU145, LNCaP, PC3) | magnetic field, 50/60 Hz, power transmission line | 0.2–2.5 mT |
Livingston GK et al. | 1991 | intact cell/cell culture, human peripheral blood lymphocytes and Chinese hamster ovary (CHO) cells | magnetic field, 50/60 Hz, electric current application | 0.22 mT |
Pasi F et al. | 2016 | intact cell/cell culture, primary human dermal fibroblasts | magnetic field, 50/60 Hz, therapeutic/medical device | 0.25–1.6 mT |
Amaroli A et al. | 2013 | intact cell/cell culture, slime mold <i>Dictyostelium discoideum</i> | magnetic field, 50/60 Hz | 300 µT |
Lee YJ et al. | 2016 | intact cell/cell culture, CD4<sup>+</sup> T cells derived from mice (C57/BL6 mice and Foxp3-GFP mice) | magnetic field, 50/60 Hz | 0.3 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.